What is NDC 65219-656?

65219-656 is the product NDC for Potassium Phosphates, Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Monobasic potassium phosphate, Dibasic potassium phosphate.

Fresenius Kabi USA, LLC, NDC labeler code 65219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Phosphates?

22 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Phosphates NDC 65219-656

NDC codes

FDA NDC Directory

Product NDC (as listed)65219-656Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65219-0656Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65219-656-10	6521906561065219065610	24 POUCH in 1 CARTON (65219-656-10) / 1 BAG in 1 POUCH (65219-656-01) / 100 mL in 1 BAGMarketed from Jun 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Phosphates
Generic name (nonproprietary): potassium phosphates
Active ingredients: Monobasic potassium phosphate — 11.2 mg/mLDibasic potassium phosphate — 11.8 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 65219
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 212832
Marketing start: Jun 15, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 65219-656_b813e96f-27c8-4bb1-ba28-6319ee823a14SPL ID b813e96f-27c8-4bb1-ba28-6319ee823a14SPL set ID 357c3020-ea6f-4401-a2e7-cebb82b03144RxCUI 2688947, 2716829UNII CI71S98N1Z, 4J9FJ0HL51
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219065610 followed by a unit qualifier and the quantity

Package 65219-0656-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2025.

Indications (excerpt from the label)

Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated. Potassium Phosphates in Sodium Chloride Injection is a phosphorus replacement product indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65219-656

What is NDC 65219-656?: 65219-656 is the product NDC for Potassium Phosphates, Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Phosphates.
What is the active ingredient?: Monobasic potassium phosphate, Dibasic potassium phosphate.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 65219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Phosphates?: 22 other product NDCs are listed under this name. See all Potassium Phosphates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Phosphates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-194	65145-0194-25
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-195	65145-0195-25
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-196	65145-0196-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-786	68462-0786-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-787	68462-0787-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-788	68462-0788-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-0032	00409-0032-01
Potassium Phosphates	Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-658	65219-0658-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	InjectionIntravenous	Cipla USA Inc.	69097-055	69097-0055-97
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	InjectionIntravenous	Cipla USA Inc.	69097-077	69097-0077-97

All 23 Potassium Phosphates NDCs

Other NDCs under NDA 212832

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 212832
Product	Strength	Form · route	Labeler	Product NDC
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	65219-052
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	65219-054
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	65219-056
Potassium Phosphates	Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-658
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	CIVICA, INC.	72572-232